METHAMPHETAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methamphetamine, and when can generic versions of Methamphetamine launch?
Methamphetamine is a drug marketed by Able, Dr Reddys Labs Sa, Hikma, Rexar, and Teva. and is included in five NDAs.
The generic ingredient in METHAMPHETAMINE is methamphetamine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methamphetamine
A generic version of METHAMPHETAMINE was approved as methamphetamine hydrochloride by DR REDDYS LABS SA on April 21st, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHAMPHETAMINE?
- What are the global sales for METHAMPHETAMINE?
- What is Average Wholesale Price for METHAMPHETAMINE?
Summary for METHAMPHETAMINE
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 5 |
Drug Prices: | Drug price information for METHAMPHETAMINE |
DailyMed Link: | METHAMPHETAMINE at DailyMed |